ZYME Q2 2018 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+1539.3% YoY

Gross Profit

$7M30.1% margin

Operating Income

-$2M-9.2% margin

Net Income

-$6M-26.7% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+54900.0%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$211M

Total Liabilities

$25M

Stockholders' Equity

$186M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$1M	+1539.3%
Gross Profit	$7M	-$7M	+195.5%
Operating Income	-$2M	-$9M	+78.2%
Net Income	-$6M	-$11M	+46.4%

Revenue Segments

License

$4M99%

Service, Other

$40,0001%